Effect of previous anticoagulant treatment on risk of COVID-19

Simple item page
dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Psiquiatría, Radioloxía, Saúde Pública, Enfermaría e Medicinagl
dc.contributor.authorZapata Cachafeiro, Maruxa
dc.contributor.authorPrieto Campo, Ángela
dc.contributor.authorPortela Romero, Manuel
dc.contributor.authorCarracedo Martínez, Eduardo
dc.contributor.authorLema Oreiro, Martina
dc.contributor.authorPiñeiro Lamas, María
dc.contributor.authorChaudhuri, Somnath
dc.contributor.authorSalgado Barreira, Ángel
dc.contributor.authorFigueiras Guzmán, Adolfo
dc.date.accessioned2023-01-24T12:04:58Z
dc.date.available2023-01-24T12:04:58Z
dc.date.issued2022
dc.description.abstractIntroduction: Little is known about the role played by anticoagulants in COVID-19. Objective: The aim of this study was to assess the impact of previous anticoagulant treatment on risk of hospitalization due to COVID-19, progression to severe COVID-19 and susceptibility to COVID-19 infection. Methods: We conducted a multiple population-based case–control study in northwest Spain, in 2020, to assess (1) risk of hospitalization: cases were all patients admitted due to COVID-19 with PCR confirmation, and controls were a random matched sample of subjects without a positive PCR; (2) progression: cases were hospitalized COVID-19 subjects, and controls were all non-hospitalized COVID-19 patients; and (3) susceptibility: cases were patients with a positive PCR (hospitalized and non-hospitalized), and the controls were the same as for the hospitalization model. Adjusted odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated using a generalized linear mixed modelgl
dc.description.peerreviewedSIgl
dc.identifier.citationZapata-Cachafeiro, M., Prieto-Campo, Á., Portela-Romero, M. et al. Effect of Previous Anticoagulant Treatment on Risk of COVID-19. Drug Saf (2022). https://doi.org/10.1007/s40264-022-01266-0gl
dc.identifier.dois40264-022-01266-0
dc.identifier.essn1179-1942
dc.identifier.issn0114-5916
dc.identifier.urihttp://hdl.handle.net/10347/29998
dc.language.isoenggl
dc.publisherSpringergl
dc.relation.publisherversionhttps://doi.org/10.1007/s40264-022-01266-0gl
dc.rights© 2022 The Authors. This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/gl
dc.rightsAtribución-NoComercial 4.0 Internacional
dc.rights.accessRightsopen accessgl
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.titleEffect of previous anticoagulant treatment on risk of COVID-19gl
dc.typejournal articlegl
dc.type.hasVersionVoRgl
dspace.entity.typePublication
relation.isAuthorOfPublication0b322a46-7514-4e0e-a63d-fa420104246f
relation.isAuthorOfPublication980a4649-5d9a-4ba4-9f77-5bc5895aeb6e
relation.isAuthorOfPublication72c1b02b-5726-4b24-84a4-481e1591b6b5
relation.isAuthorOfPublication.latestForDiscovery0b322a46-7514-4e0e-a63d-fa420104246f

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2022_drug_zapata_effect.pdf
Size:
723.68 KB
Format:
Adobe Portable Document Format
Description:
Artigo de investigación
Download

Collections

Psiquiatría, Radioloxía, Saúde Pública, Enfermaría e Medicina